U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ANTHRASIL
  1. Approved Blood Products

STN: 125562
Proper Name: Anthrax Immune Globulin Intravenous (Human)
Tradename: ANTHRASIL
Manufacturer: Cangene Corporation
Indication: 

  •  Indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs

Product Information

Supporting Documents

Back to Top